Hypoxic-Ischemic Encephalopathy study: Wireless NIRS
Official title Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit
ClinicalTrials.gov ID: NCT07732244
What this study is testing
- What it's testing
- The study will look at whether removing and reapplying the sensor during routine skin checks changes the sensor’s signal quality.
- Who it's for
- Newborn infants in the NICU who have hypoxic‑ischemic encephalopathy, congenital heart disease, hemorrhagic stroke, or cerebral aneurysm.
- What's involved
- A wireless NIRS sensor will be placed on the baby’s forehead for 4 hours each day over two days. The research team will remove and reapply the sensor at each nursing check, noting the time and skin condition.
- Time commitment
- The study lasts two days, with the sensor on for 4 hours each day and visits at each routine nursing check.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Infants admitted to the NICU with a gestational age of ≥ 32 weeks at the time of the monitoring
- undergoing monitoring with the INVOS wired NIRS system.
You likely can't join if
- Infants with a skin abnormality that would potentially increase the risk of injury,
- Patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for...
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.